or Try an Advanced Search...

    Technical Analysis for CSTL - Castle Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 31.42 -1.46% -0.47
    CSTL closed down 1.46 percent on Thursday, December 5, 2024, on 17 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CSTL trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Crossed Above 50 DMA Bullish -1.46%
    Fell Below 50 DMA Bearish 2.06%
    20 DMA Support Bullish 2.06%
    Inside Day Range Contraction 2.06%
    Crossed Above 20 DMA Bullish 0.05%
    Crossed Above 50 DMA Bullish 0.05%
    MACD Bullish Signal Line Cross Bullish 0.05%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.05%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.05%
    Older End-of-Day Signals for CSTL ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 6 hours ago
    Rose Above Previous Day's High about 6 hours ago
    Up 1% about 6 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Down 2 % about 8 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CSTL Chart by TradingView
    Basic chart:

    Profile

    Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Cancer Clinical Medicine Melanoma Medical Test Gene Expression Metastasis Dsw Uveal Melanoma

    Is CSTL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Dec 4 JANX Stock Hits Record High on Prostate Cancer Study Data
    Dec 3 PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy
    Nov 28 Grifols Stock Declines After Brookfield Drops Buyout Offer
    Nov 28 Small Caps Are Winners of 2024: 5 Picks With Solid Short-Term Upside
    Nov 26 AstraZeneca's Combination Therapy Meets Goal in Prostate Cancer Study
    Nov 25 Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?
    Nov 21 JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer
    Nov 20 Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference
    Nov 19 CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
    Nov 19 Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year
    See more CSTL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 35.84
    52 Week Low 16.965
    Average Volume 388,264
    200-Day Moving Average 25.26
    50-Day Moving Average 31.06
    20-Day Moving Average 30.70
    10-Day Moving Average 30.50
    Average True Range 1.59
    RSI (14) 52.61
    ADX 17.42
    +DI 16.81
    -DI 15.95
    Chandelier Exit (Long, 3 ATRs) 31.08
    Chandelier Exit (Short, 3 ATRs) 32.00
    Upper Bollinger Bands 34.16
    Lower Bollinger Band 27.25
    Percent B (%b) 0.6
    BandWidth 22.52
    MACD Line -0.11
    MACD Signal Line -0.31
    MACD Histogram 0.2065
    Fundamentals Value
    Market Cap 845.39 Million
    Num Shares 26.9 Million
    EPS -2.84
    Price-to-Earnings (P/E) Ratio -11.06
    Price-to-Sales 3.35
    Price-to-Book 1.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 32.86
    Resistance 3 (R3) 32.90 32.47 32.62
    Resistance 2 (R2) 32.47 32.10 32.44 32.53
    Resistance 1 (R1) 31.94 31.87 31.72 31.90 32.45
    Pivot Point 31.51 31.51 31.40 31.48 31.51
    Support 1 (S1) 30.98 31.14 30.76 30.94 30.38
    Support 2 (S2) 30.55 30.91 30.52 30.30
    Support 3 (S3) 30.02 30.55 30.22
    Support 4 (S4) 29.98